Abstract:Background: We recently found that circular RNA- gamma -secretase-activating protein (circGSAP) down-regulation in peripheral blood mononuclear cells was associated with the occurrence and outcomes of idiopathic pulmonary arterial hypertension (IPAH). We aimed to demonstrate that the underlying mechanisms of circGSAP regulate pulmonary microvascular endothelial cells (PMECs) dysfunction by absorbing microRNA to inhibit target genes in IPAH.Methods: Quantitative real-time polymerase chain reaction, immunofluorescence staining, Cell Counting Kit-8, Calcein-AM/PI staining and Transwell and dual-luciferase reporter assays were used to clarify the roles of circGSAP.Findings: CircGSAP levels were decreased in the plasma of patients with IPAH and were associated with poor outcomes. In monocrotaline-induced PH rats, circGSAP overexpression decreased mortality, and improved pulmonary vascular remodelling and right ventricular remodelling. CircGSAP overexpression inhibited hypoxia-induced PMECs proliferation, migration and mortality by absorbing miR-27a-3p. BMPR2 was identified as a miR-27a-3p target gene. BMPR2 levels were up-regulated in PMECs treated with circGSAP plasmid and down-regulated in hypoxia-treated PMECs. The effects of small interfering RNA (siRNA) circGSAP on PMECs proliferation, migration and mortality were mitigated via a miR-27a-3p inhibitor. Similarly, siRNA BMPR2 ameliorated the effect of the miR-27a-3p inhibitor on PMECs proliferation and migration.Interpretation: Our findings demonstrated that down-regulated circGSAP facilitates PMECs dysfunction by competitively binding with miR- 27a-3p leading to decreased BMPR2 expression, indicating potential therapeutic strategies for IPAH.Funding Information: This work was supported by funding from theProgram of National Natural Science Foundation of China (81870042, 81700045, and 81900050) and Program of Natural Science Foundation of Shanghai (21ZR1453800, 201409004100 and 18ZR1431500).Declaration of Interests: None.Ethics Approval Statement: This study was approved and supervised by the Ethics Committee of Shanghai Pulmonary Hospital (number: K20-150Y). Written informed consent was obtained from all participants. The experiments conformed to the Guide for the Care and Use of Laboratory Animals of the Institute for Laboratory Animal Research at the Experimental Animal Centre of Tongji University, Shanghai, China.

CircGSAP Alleviates the Dysfunction of Pulmonary Microvascular Endothelial Cells via BMPR2&nbsp;Signalling Pathway

CircGSAP regulates the cell cycle of pulmonary microvascular endothelial cells via the miR-942-5p sponge in pulmonary hypertension

CircGSAP alleviates pulmonary microvascular endothelial cells dysfunction in pulmonary hypertension via regulating miR-27a-3p/BMPR2 axis

The Role of TGF-β or BMPR2 Signaling Pathway-Related Mirna in Pulmonary Arterial Hypertension and Systemic Sclerosis

Endothelial Progenitor Cells May Inhibit Apoptosis of Pulmonary Microvascular Endothelial Cells: New Insights into Cell Therapy for Pulmonary Arterial Hypertension

Involvement of CapG in Proliferation and Apoptosis of Pulmonary Arterial Smooth Muscle Cells and in Hypoxia-Induced Pulmonary Hypertension Rat Model

CircALMS1 Alleviates Pulmonary Microvascular Endothelial Cell Dysfunction in Pulmonary Hypertension.

CircATP2B4 promotes hypoxia-induced proliferation and migration of pulmonary arterial smooth muscle cells via the miR-223/ATR axis

CircST6GAL1 knockdown alleviates pulmonary arterial hypertension by regulating miR‐509‐5p/multiple C2 and transmembrane domain containing 2 axis

Abstract 15826: SCUBE1 Controls BMPR2-relevant Pulmonary Endothelial Function: Implications for Diagnostic Marker Development in Pulmonary Arterial Hypertension

CircItgb5 promotes synthetic phenotype of pulmonary artery smooth muscle cells via interacting with miR-96-5p and Uba1 in monocrotaline-induced pulmonary arterial hypertension

Evaluating the Effect of Circ-Sirt1 on the Expression of SIRT1 and Its Role in Pathology of Pulmonary Hypertension

MicroRNA‐483 Amelioration of Experimental Pulmonary Hypertension

Circular RNA Sirtuin1 represses pulmonary artery smooth muscle cell proliferation, migration and autophagy to ameliorate pulmonary hypertension via targeting microRNA-145-5p/protein kinase-B3 axis

Abstract 108: Mediator 1 Regulation of the BMP / TGF-β Signaling in Endothelium: Implications for Pulmonary Hypertension

NCAPG Promotes Pulmonary Artery Smooth Muscle Cell Proliferation as a Promising Therapeutic Target of Idiopathic Pulmonary Hypertension: Bioinformatics Analysis and Experiment Verification

PPARγ-p53-Mediated Vasculoregenerative Program to Reverse Pulmonary Hypertension

CircPMS1 Promotes Proliferation of Pulmonary Artery Smooth Muscle Cells, Pulmonary Microvascular Endothelial Cells, and Pericytes under Hypoxia.

Combination treatment of adipose-derived stem cells and adiponectin attenuates pulmonary arterial hypertension in rats by inhibiting pulmonary arterial smooth muscle cell proliferation and regulating the AMPK/BMP/Smad pathway Corrigendum in /10.3892/ijmm.2021.4953

Reduced CircSMOC1 Level Promotes Metabolic Reprogramming via PTBP1 (Polypyrimidine Tract-Binding Protein) and miR-329-3p in Pulmonary Arterial Hypertension Rats

Alleviating experimental pulmonary hypertension<i> via</i> co-delivering FoxO1 stimulus and apoptosis activator to hyperproliferating pulmonary arteries

CircGSAP Alleviates the Dysfunction of Pulmonary Microvascular Endothelial Cells via BMPR2&amp;nbsp;Signalling Pathway